Kindstar Globalgene Technology, Inc. (HKG:9960)
Hong Kong · Delayed Price · Currency is HKD
1.160
+0.010 (0.87%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 585.11M | 590.31M | 525.80M | 535.27M | 469.33M | | |
Hematology Testing Growth | -0.88% | 12.27% | -1.77% | 14.05% | -2.80% | | |
Scientific research services and CRO | 44.66M | 26.39M | 7.94M | - | - | | |
Scientific research services and CRO Growth | 69.20% | 232.53% | - | - | - | | |
| 42.39M | 57.47M | 57.44M | 67.67M | 67.54M | | |
| -26.24% | 0.06% | -15.12% | 0.20% | -18.07% | | |
| 21.72M | 32.06M | 17.87M | 8.62M | 7.60M | | |
| -32.25% | 79.41% | 107.45% | 13.40% | 11.95% | | |
| 39.43M | 49.00M | 47.69M | 51.97M | 50.44M | | |
Infectious Diseases Growth | -19.53% | 2.74% | -8.23% | 3.03% | -21.70% | | |
Maternity-Related Testing | 53.88M | 55.42M | 49.96M | 52.25M | 52.12M | | |
Maternity-Related Testing Growth | -2.77% | 10.92% | -4.38% | 0.25% | -18.72% | | |
| 95.35M | 96.60M | 95.35M | 89.85M | 76.04M | | |
| -1.30% | 1.31% | 6.12% | 18.16% | -6.35% | | |
| 277.00K | 13.29M | 5.14M | 19.46M | 14.30M | | |
| -97.91% | 158.66% | -73.60% | 36.10% | 52.33% | | |
Genetic Disease and Rare Diseases | 44.75M | 46.72M | 42.78M | 43.50M | 36.18M | | |
Genetic Disease and Rare Diseases Growth | -4.21% | 9.20% | -1.65% | 20.23% | -13.06% | | |
| - | - | 536.63M | 62.10M | 117.85M | | |
COVID-19 Related Testing Growth | - | - | 764.07% | -47.30% | - | | |
| 927.57M | 967.26M | 1.39B | 930.67M | 891.39M | | |
| -4.10% | -30.24% | 48.99% | 4.41% | 7.04% | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 927.57M | 967.26M | 1.39B | 930.67M | 891.39M | | |
| -4.10% | -30.24% | 48.99% | 4.41% | 7.04% | | |
| 927.57M | 967.26M | 1.39B | 930.67M | 891.39M | | |
| -4.10% | -30.24% | 48.99% | 4.41% | 7.04% | | |
Source: S&P Global Market Intelligence.
